IDEAS home Printed from https://ideas.repec.org/a/sae/medema/v22y2002i1_supplp3-10.html
   My bibliography  Save this article

Analytic Tools for Public Health Decision Making

Author

Listed:
  • Douglas K. Owens

Abstract

No abstract is available for this item.

Suggested Citation

  • Douglas K. Owens, 2002. "Analytic Tools for Public Health Decision Making," Medical Decision Making, , vol. 22(1_suppl), pages 3-10, September.
    • Handle: RePEc:sae:medema:v:22:y:2002:i:1_suppl:p:3-10
    DOI: 10.1177/027298902237969
    as

    Download full text from publisher

    File URL: https://journals.sagepub.com/doi/10.1177/027298902237969
    Download Restriction: no
    File URL: https://libkey.io/10.1177/027298902237969?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Allan S. Detsky & Gary Naglie & Murray D. Krahn & David Naimark & Donald A. Redelmeier, 1997. "Primer on Medical Decision Analysis: Part 1—Getting Started," Medical Decision Making, , vol. 17(2), pages 123-125, April.
    2. Douglas K. Owens & Ross D. Shachter & Robert F. Nease JR, 1997. "Representation and Analysis of Medical Decision Problems with Influence Diagrams," Medical Decision Making, , vol. 17(3), pages 241-262, July.
    3. Nathaniel Hupert & Alvin I. Mushlin & Mark A. Callahan, 2002. "Modeling the Public Health Response to Bioterrorism: Using Discrete Event Simulation to Design Antibiotic Distribution Centers," Medical Decision Making, , vol. 22(1_suppl), pages 17-25, September.
    4. Joseph M. Mrus & Michael S. Yi & Mark H. Eckman & Joel Tsevat, 2002. "The Impact of Expected HIV Transmission Rates on the Effectiveness and Cost of Ruling Out HIV Infection in Infants," Medical Decision Making, , vol. 22(1_suppl), pages 38-44, September.
    5. Fujian Song & James Raftery & Paul Aveyard & Chris Hyde & Pelham Barton & Nerys Woolacott, 2002. "Cost-Effectiveness of Pharmacological Interventions for Smoking Cessation: A Literature Review and a Decision Analytic Analysis," Medical Decision Making, , vol. 22(1_suppl), pages 26-37, September.
    6. Gary Naglie & Murray D. Krahn & David Naimark & Donald A. Redelmeier & Allan S. Detsky, 1997. "Primer on Medical Decision Analysis: Part 3—Estimating Probabilities and Utilities," Medical Decision Making, , vol. 17(2), pages 136-141, April.
    7. Edward C. Mansley & Diane O. Duñet & Daniel S. May & Sajal K. Chattopadhyay & Matthew T. Mckenna, 2002. "Variation in Average Costs among Federally Sponsored State-Organized Cancer Detection Programs: Economies of Scale?," Medical Decision Making, , vol. 22(1_suppl), pages 67-79, September.
    8. Marie-Josée Dion & Pierre Tousignant & Jean Bourbeau & Dick Menzies & Kevin Schwartzman, 2002. "Measurement of Health Preferences among Patients with Tuberculous Infection and Disease," Medical Decision Making, , vol. 22(1_suppl), pages 102-114, September.
    9. Patricia Vold Pepper & Douglas K. Owens, 2002. "Cost-Effectiveness of the Pneumococcal Vaccine in Healthy Younger Adults," Medical Decision Making, , vol. 22(1_suppl), pages 45-57, September.
    10. Phaedra S. Corso & James K. Hammitt & John D. Graham & Richard C. Dicker & Sue J. Goldie, 2002. "Assessing Preferences for Prevention versus Treatment Using Willingness to Pay," Medical Decision Making, , vol. 22(1_suppl), pages 92-101, September.
    11. Faruque Ahmed & Elamin E. Elbasha & Betsy L. Thompson & Jeffrey R. Harris & Vishnu-Priya Sneller, 2002. "Cost-Benefit Analysis of a New HEDIS Performance Measure for Pneumococcal Vaccination," Medical Decision Making, , vol. 22(1_suppl), pages 58-66, September.
    12. Murray D. Krahn & Gary Naglie & David Naimark & Donald A. Redelmeier & Allan S. Detsky, 1997. "Primer on Medical Decision Analysis: Part 4-Analyzing the Model and Interpreting the Results," Medical Decision Making, , vol. 17(2), pages 142-151, April.
    13. Frank A. Sonnenberg & J. Robert Beck, 1993. "Markov Models in Medical Decision Making," Medical Decision Making, , vol. 13(4), pages 322-338, December.
    14. Garber, Alan M. & Phelps, Charles E., 1997. "Economic foundations of cost-effectiveness analysis," Journal of Health Economics, Elsevier, vol. 16(1), pages 1-31, February.
    15. Phaedra S. Corso & Stephen B. Thacker & Jeffrey P. Koplan, 2002. "The Value of Prevention: Experiences of a Public Health Agency," Medical Decision Making, , vol. 22(1_suppl), pages 11-16, September.
    16. Robert F. Nease JR & Douglas K. Owens, 1997. "Use of Influence Diagrams to Structure Medical Decisions," Medical Decision Making, , vol. 17(3), pages 263-275, July.
    17. Stephanie R. Earnshaw & Anke Richter & Stephen W. Sorensen & Thomas J. Hoerger & Katherine A. Hicks & Michael Engelgau & Ted Thompson & K. M. Venkat Narayan & David F. Williamson & Edward Gregg & Ping, 2002. "Optimal Allocation of Resources across Four Interventions for Type 2 Diabetes," Medical Decision Making, , vol. 22(1_suppl), pages 80-91, September.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Adhikari, Bishwa B. & Angulo, Frederick & Meltzer, Martin, 2004. "Economic Burden Of Salmonella Infections In The United States," 2004 Annual meeting, August 1-4, Denver, CO 20050, American Agricultural Economics Association (New Name 2008: Agricultural and Applied Economics Association).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Stephen G. Pauker & John B. Wong, 2005. "The Influence of Influence Diagrams in Medicine," Decision Analysis, INFORMS, vol. 2(4), pages 238-244, December.
    2. Juhee Lee & Peter F. Thall & Bora Lim & Pavlos Msaouel, 2022. "Utility‐based Bayesian personalized treatment selection for advanced breast cancer," Journal of the Royal Statistical Society Series C, Royal Statistical Society, vol. 71(5), pages 1605-1622, November.
    3. Bielza, Concha & Gómez, Manuel & Shenoy, Prakash P., 2011. "A review of representation issues and modeling challenges with influence diagrams," Omega, Elsevier, vol. 39(3), pages 227-241, June.
    4. Herrera-Araujo, Daniel & Hammitt, James K. & Rheinberger, Christoph M., 2020. "Theoretical bounds on the value of improved health," Journal of Health Economics, Elsevier, vol. 72(C).
    5. Mark Sculpher & David Torgerson & Ron Goeree & Bernie O'Brien, 1999. "A critical structured review of economic evaluations of interventions for the prevention and treatment of osteoporosis," Working Papers 169chedp, Centre for Health Economics, University of York.
    6. B. Brüggenjürgen & P. Lindgren & B. Ehlken & H.-J. Rupprecht & S. Willich, 2007. "Long-term cost-effectiveness of clopidogrel in patients with acute coronary syndrome without ST-segment elevation in Germany," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 8(1), pages 51-57, March.
    7. Marta O Soares & L Canto e Castro, 2010. "Simulation or cohort models? Continuous time simulation and discretized Markov models to estimate cost-effectiveness," Working Papers 056cherp, Centre for Health Economics, University of York.
    8. K. Claxton & P. J. Neumannn & S. S. Araki & M. C. Weinstein, "undated". "Bayesian Value-of-Information Analysis: An Application to a Policy Model of Alzheimer's Disease," Discussion Papers 00/39, Department of Economics, University of York.
    9. Braden Manns & David Meltzer & Ken Taub & Cam Donaldson, 2003. "Illustrating the impact of including future costs in economic evaluations: an application to end‐stage renal disease care," Health Economics, John Wiley & Sons, Ltd., vol. 12(11), pages 949-958, November.
    10. Andrew J. Mirelman & Miqdad Asaria & Bryony Dawkins & Susan Griffin & Richard Cookson & Peter Berman, 2020. "Fairer Decisions, Better Health for All: Health Equity and Cost-Effectiveness Analysis," World Scientific Book Chapters, in: Paul Revill & Marc Suhrcke & Rodrigo Moreno-Serra & Mark Sculpher (ed.), Global Health Economics Shaping Health Policy in Low- and Middle-Income Countries, chapter 4, pages 99-132, World Scientific Publishing Co. Pte. Ltd..
    11. Scott Johnson & Matthew Davis & Anna Kaltenboeck & Howard Birnbaum & ElizaBeth Grubb & Marcy Tarrants & Andrew Siderowf, 2011. "Early retirement and income loss in patients with early and advanced Parkinson’s disease," Applied Health Economics and Health Policy, Springer, vol. 9(6), pages 367-376, November.
    12. Linus Nyiwul, 2021. "Epidemic Control and Resource Allocation: Approaches and Implications for the Management of COVID-19," Studies in Microeconomics, , vol. 9(2), pages 283-305, December.
    13. P. Daniel Wright & Matthew J. Liberatore & Robert L. Nydick, 2006. "A Survey of Operations Research Models and Applications in Homeland Security," Interfaces, INFORMS, vol. 36(6), pages 514-529, December.
    14. Eva K. Lee & Siddhartha Maheshwary & Jacquelyn Mason & William Glisson, 2006. "Large-Scale Dispensing for Emergency Response to Bioterrorism and Infectious-Disease Outbreak," Interfaces, INFORMS, vol. 36(6), pages 591-607, December.
    15. Malek B Hannouf & Chander Sehgal & Jeffrey Q Cao & Joseph D Mocanu & Eric Winquist & Gregory S Zaric, 2012. "Cost-Effectiveness of Adding Cetuximab to Platinum-Based Chemotherapy for First-Line Treatment of Recurrent or Metastatic Head and Neck Cancer," PLOS ONE, Public Library of Science, vol. 7(6), pages 1-9, June.
    16. Bärnighausen, Till & Bloom, David E., 2009. ""Conditional scholarships" for HIV/AIDS health workers: Educating and retaining the workforce to provide antiretroviral treatment in sub-Saharan Africa," Social Science & Medicine, Elsevier, vol. 68(3), pages 544-551, February.
    17. McKenna, Claire & Chalabi, Zaid & Epstein, David & Claxton, Karl, 2010. "Budgetary policies and available actions: A generalisation of decision rules for allocation and research decisions," Journal of Health Economics, Elsevier, vol. 29(1), pages 170-181, January.
    18. David Meltzer & Magnus Johannesson, 1999. "Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine," Medical Decision Making, , vol. 19(4), pages 371-377, October.
    19. Glenn Jenkins & CHUN-YAN KUO & JOHN GIRALDEZ, 2007. "Canadian Regulatory Cost-Benefit Analysis Guide," Development Discussion Papers 2007-03, JDI Executive Programs.
    20. Kevin Haninger & James K. Hammitt, 2011. "Diminishing Willingness to Pay per Quality‐Adjusted Life Year: Valuing Acute Foodborne Illness," Risk Analysis, John Wiley & Sons, vol. 31(9), pages 1363-1380, September.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:sae:medema:v:22:y:2002:i:1_suppl:p:3-10. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: SAGE Publications (email available below). General contact details of provider: .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.